MyFinsight
Home
Blog
About
Contact
Download
Download image
Depreciation and
amortization
$47,011K
Income (loss) from
continuing operations
$27,274K
Equity-based compensation
$12,673K
Inventory
-$8,569K
Provision (benefit) for
expected credit losses
$1,256K
Other, net
$1,161K
Loss on
extinguishment
-$326K
Loss on disposals
-$81K
Net cash from
operating activities -...
$74,673K
Canceled cashflow
$23,678K
Net cash from
operating activities
$74,673K
Effect of exchange rate
changes on cash
$371K
Accounts payable and
accrued expenses
-$19,814K
Other current and
noncurrent assets and...
$1,679K
Accounts receivable
$916K
Deferred income taxes
-$909K
Unrealized (gain) loss on
foreign currency...
$360K
Net change in cash
and cash...
$9,656K
Canceled cashflow
$65,388K
Borrowing on revolver
$45,000K
Proceeds from the
issuance of long-term...
$31,907K
Proceeds from issuance of
class a and b common...
$2,074K
Net cash from
financing activities
-$62,140K
Net cash from
investing activities
-$3,248K
Canceled cashflow
$78,981K
Payments on the
extinguishment of long-term...
$65,765K
Net cash from
investing activities -...
-$3,248K
Payment on revolver
$45,000K
Payment of contingent
consideration
$19,771K
Payments on long-term
debt
$9,052K
Other, net
-$827K
Debt financing costs
$697K
Tax withholdings on
equity-based compensation
$9K
Purchase of property and
equipment
$2,562K
(settlement) proceeds from
the sale of a...
-$686K
Back
Back
Cash Flow
source: myfinsight.com
Bioventus Inc. (BVS)
Bioventus Inc. (BVS)